Lucas brings several years of experience as a research scientist to his practice in L&A’s Life Sciences group, where he assists in the drafting and prosecution of U.S. and foreign patent applications, and in the preparation of freedom to operate and patentability analyses. Immediately prior to joining the firm, Lucas was a life sciences technology specialist in the Boston office of an AmLaw 100 law firm where he drafted and prosecuted patent applications related to antibody and nucleic acid technologies and therapeutics. His research background includes working at a biotechnology company, where he focused on the development antisense oligonucleotide therapeutics for infectious diseases, as well as working as a senior scientist at a non-profit research institute, where he co-developed synthetic biology tools to engineer biological components for microbial-based biosensors.
Lucas holds a Ph.D. in microbiology and molecular genetics from the University of Vermont and conducted his post-doctoral research at the Whitehead Institute for Biomedical Research. Both his Ph.D. thesis and post-doctoral work focused on anti-infective drug target identification and validation. He received a B.S. in microbiology from Oregon State University, where he conducted undergraduate research on the isolation and characterization of ancient DNA from archaeological stone-tool artifacts.
Lucas is an inventor on U.S. patents related to antisense technology and is an author of several scientific articles published in Antimicrobial Agents & Chemotherapy, Journal of Antimicrobial Chemotherapy, Proceedings of the National Academy of Sciences of the United States of America, PLoS ONE, and the Journal of Archaeological Science.